Liver Pathophys Flashcards

1
Q

psychometric testing

A

sensitive for detecting impairment in mild HE

lead to the identificaltion of minimal HE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Wilson’s Disease

A

inadequate copper excretion and failure of copper to ener circulation as ceruloplasmin –> multiorgan Cu accumulation

ATP7B genetic defect with Autosomal recessive (in hepatocytes, transfers Cu into secretory pway by binding it to ceruloplasmin and facilitates biliary excretion)

Basal ganglia degernation - depression, parkinsons

Ceruloplasmin decreases, Cirrhosis, Corneal deposits (KF rings) Copper accumulation, Caricnoma (hepatocellular)

Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A

interface hepatitis - AIH

mononuclear infiltrate invading through the limiting plate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lab tests to assess liver disease progression

A

fibrosis, cirrhosis, seerity

proteins involved in EC matrix modeling and other blood tests

not gret yet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hepatopulmonary Syndrome

A

present when this triad:

1. Liver disease

2. impaired oxygenation

3. intrapulmonary vascular dilations (IPVDS)

decreased GFR

decreased renal perfusion

absence of identifiable cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Labs in Wilson’s

A

low serum ceruloplasmin (if not bound to copper, short half life and degraded quickly)

low serum Cu (serum Cu actually means Cu bound to ceruloplasmin which is low)

high urinary Cu (unbound Cu excreted by kidneys)

High heaptic Cu (biopsy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

portal htn in portal vein?

A

hypercoag

trauma

malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

direct bilirubin

A

conjugated Bb is water soluble and can be measred “directly” using colorimetric methods - dye in serum, measure normally

Normal value is very low. It is about .1-.3mg/dL because the liver is putting out that conjugated bilirubin. So it is not circulating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

unconjugated hyperbilirubinemia

A

defective uptake and conjugation

inhereted (defects in UDPGT)

liver immaturing (physiologic jaundice of newborns Bb = 4-5)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Natural history of NAFLD

A

20% progress to NASH

11% progress to cirrhosis (possible decompensation)

both can progress to HCC

increased mortality

80% have fatty liver

min progression to cirrhosis

increased CV, diabetes risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hepatitis C labs

A

mostly becomes chronic

develop anti-HCV but it’s not protective

can have ab and may be chronically infected

•You can measure in the acute phase as well as the chronic phase the virus. The antibodies doesn’t tell you that the patient isn’t immune any longer. It is just evidence that they have been affected as some point. It is not like the surface antibodies in HBV that tells you the patient is immune. Most of these people don’t recover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

treatment of HDV

A

treat HBV

if clear HBV will clear HDV

interferon is only therapy against HDV!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HCV genotype

A

6!

1a/1b in US

imp for treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

labs in liver failure

A

increased Bb (T and D)

hypoalbuminemia

increased PT (INR)

increased ammonia –> encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NAFLD

A

30% of americans have NAFLD

dyslipidemia

obesity

T2D

comprises “fatty liver” and NASH

fat droplets in the hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PSC and IBD

A

80% have concimitent IBD

IBD patients have increased risk of PSC

more colitis = greater risk

must do colo to evaluated for IBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment for herediatry hemochromatosis

A

goal is ferritin <50

phlebotomy is gold standard - improes fatigue, liver enzymes, skin, varices

does not improve arthralgias

may imrpove diabetes or cardiac

weekly for 2 years then maintenence every 3 months for life

screening of relatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

prescott nomogram

A

risk of toxicity for acetaminophen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

primary sclerosing cholangitis

A

chronic progressive cholestatic disease of both intra and extra hepatic ducts

inflammation and fibrosis of bile ducts - stricutres and dilation

80% have concomitant IBD (UC more)

progressive risk of cholangicarcinoma, HCC, gallbladder cancer

only treatment is liver transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

conjugated bilirubin

A

direct - water soluble

•Conjugated bilirubin: the bilirubin has already been glucuronized and can be excreted into the bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Course of herediatry hemocrhomatosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Autoimmune sclerosing cholangitis

A

AIH = PSC

like PSC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

transient elastography

A

measures liver tissue elasticity by measuring speed of vbrations through parenchma

detect advanced fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clinical manifestations of herediary hemochromatosis

A
  1. biochemical - steady increase in Fe stores from birth, clinically quiescent
  2. parenchymal accumulation - elevated ferritin, clinically quiescent
  3. end organ toxicity/failure - 30-50 years, cirrhosis and HCC, CCA, arrithymias and CHF, diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Tx of Wilsons
drugs: goal of negative copper balance 1. Cu chelators (trientene or D-penicillamine) 2. maintanence - Zinc, low dose chelators 3. liver transplant if acute liver failure or cirrhosis
26
hepatorenal syndrope mechanism
cirrhosis PHTN splanchnic vaodilation reduced EABV incrased vasoconstriction/antinaturesisi renal vasoconstriction HRS
27
pathogenesis of ascietes
**1. PHTN** increased hep sinusoidal P vasodilation (esp splanchnic) effective vol depletion **2. activation of endogenous vasocontrictors** ADH RAAS Sympathetic NS **3. NET: Na + water retention** increased total body Na with a dilutional hyponaturemia
28
normal ranges for ALT and AST
\< 40 IU/L
29
TIPS
transjugular intrahepatic porto-systemic shunt btwn hepatic vein and portal vein decreases P
30
LFTs for cholestasis (altered bile flow)
bilirubin (also uptake and conjugation) alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT)
31
GGT
produced by biliar epithelial cells of small interlobular bile ducts and SRE of hepatocytes increases when induction by toxins, drugs, alcohol non-specific (high in many conditions) mostly used to determine if ALP is of liver origin when both elevated - request both together •So the main use GGT is to see if the ALP that is elevated is from the liver origin. If both elevated, the most likely reason for the elevation is that they are coming from the biliary tree. So they can be associated to liver disease.
32
type I AIH autoantibodies
ANA ASMA
33
Hepatorenal syndrome
reversible renal failure that occurs in patients w advanced cirrhosis and portal hypertension ## Footnote **marked reduction in GFR** **decreased renal perfusion** **absence of identifiable cause**
34
Lab Findings in ALD
AST/ALT \>2:1 elevated GGT high ferratin (inflam marker) high bili, INR
35
Autoimmune cholangitis
AIH + AMA-negative PBC UDCA +/- steroids (variable response)
36
AIH pathogenesis
1. env trigger 2. genetics 3. autoantigen is **cyp4502D6** (**anti-LKM** ab responds to it) 4. auto reactivity (molec mimicry, T cell med cascade) 5. inflammation --\> cirrhosis
37
autoimmune hepatitis
chronic hepatitis in young to middle aged women elevation of aminotransferases positive ANA and anti-smooth muscle antibodies (type 1) or mostly in children abs to liver-kidney (type 2) * They may have elevation of aminotransferases. But as I said, there is test, not very specific, that could tell you there is hypergammaglobulinemia * These patients have hypergammaglobulinemia in addition to having autoantibodies like antinuclear antibody or anti smooth muscle antibody * So middle age women presenting with liver enzyme elevation that has a family of autoimmune diseases. perhaps you can do this type of work up: electrophoresis or autoantibody detection
38
HBV DNA level
PCR marker of **acute or chronic** infection who to treat and response to treatment
39
how much bilirubin produced daily?
250-300 mg/dL daily
40
HBV reactive phase
Rise in ALT and High HBV DNA leels i.e. if start on immunosuppression, small amt can stay in liver even if cleared
41
what do LFTs assess
hepatocellular injury (aminotransferases - ALT, AST) cholestasis -- altered bile flow (biliubin, alkaline phosphatase - ALP, GGT) synthetic functio
42
management of alcoholic hepatitis
abstinence support/ntrition steroids and/or pentoxifylline; NAC
43
synthetic liver functions
albumin clotting factors acute phase reactants bile acids other proteins
44
transferrin
transports iron in the blood can only bind 2 Fe atoms at a tome 20-45% of transferrin is bound to Fe (transferrin saturation)
45
albumin synthesis in the liver
only made in the liver! half life= 18-20 decreased synthesis in chronic liver disease and index of disease severity
46
Medictions for HBV
1. Entecavir 2. Tenofovir ^nucletide analogs - inhibit viral DNA pol, less side effects but longer treatment don't use interferons as much anymore (side effects)
47
Treatmetn of PBC?
**UDCA** is the only therapy that slows the progression of PBC and reduces need for transplant less bile acid pool hepatotoxicity and decreases inflammation give **bile acid resin**s or rifampin for pruritis
48
How do you distinguish between superinfection vs coinfection with HDV?
**superinfection:** IgM anti-HBc is negative chronic HBV! **coinfection:** IgM anti-HBc is positive acute HBV!
49
outcomes of chronic HCV
cirrhosis HCC extrahepatic
50
splanchnic vasodilation in portal HTN
NO is the mediator NO synthesis stimulated by inflammatory mediators, endo toxin, bacterial products
51
treatment of HEV
supportive care may require transplant if severe liver disease
52
primary biliar cirrhosis
chronic **autoimmune** disease targeting **small intrahepatic bile ducts** middle aged women of northern european descent **AMA** is highly specific!! 95% - on inner mitochondrial membrane for all cells progressive destruction of small intrahepatic bile ducts - chronic cholestasis - hepatocyte inflammation and necrosis - regen nodules and cirrhosis - liver failure and death
53
Natural history of NASH
steatosis NASH fibrosis cirrhosis HCC
54
Lab findings in cirrhosis
**T and D bili** **ALT/AST** **albumin** **Alk Phos** also platelets+INR (coag), sodium (hyponautremia), markers of cirrhosis
55
Clinical presentation of WIlson's disease
younger either: **acute hepatitis**: malaise, janudice, high ALT/AST, coagulopathy **chronic liver disease**: hepatosplenomegaly, portal hypertension, coagulopathy **acute LF**: coagulopathy, encephalopathy (lower ALT./AST - higher bili due to hemolysis, **\*\*low alk phos**)
56
how do you diagnose hepatic cause of ascites
diagnostic paracentesis Serum Ascites Albumin Gradient \> 1.1 Total protein (low) cell conut
57
How do you diagnose PBC?
Cholestatic LFTs asymptomatic elevation in alk phos is the most common presentation - related to degree of inflammation and ductopenia detectable serum AMA marked hypercholesterlemia (HDL - no MI risk) High serum IgM osteoporosis liver biopsy
58
HEV IgM
acute infection
59
symptoms of HAV
incubation = 2-4 wks fever, malaise, fatigue, nausea and vomiting self limted infection! increased mortality in old and liver disease pts occasional relapse w/in 6 mo - no chronic! can cause fulminant hepatits --\> liver transplant
60
ALT vs AST
ALT = more specific (in cytosol) - [AST is in many organs - increses in hemolysis, MI] ALT has a much longer halflife (takes longer to decrease after injury)
61
bilirubin synthesis pathway
* Bilirubin comes from heme of hemoglobin. * There are steps that takes place outside the liver. Takes place in reticular endothelium, spleen and other organs. * The heme is subject to an **enzyme oxygenation** that opens up this tetrapyrrol ring and is converted into something called biliverdin * Then another step is [catalyzed by] biliverbin reductase and now biliverdin is converted in bilirubin. It has been reduced * All three steps here takes place outside the liver * In the liver it gets conjugated. And this is bilirubin **diglucuronide** that we are going to mention in a few minutes. One of the important steps in the elimination of bilirubin is to conjugate it. * All of these steps. The iron is taken back in this reaction [the one catalyzed by heme oxygenase]. As the tetrapyrrol opens, it releases CO2 and Fe and it breaks down O2 etc.
62
perinatal exposure to HBV
95% will develop chronic HBV post-exposure prophylaxis with HBG and Hep B vaccine increase Hep B surface ab vaccine = long term immunity
63
alcoholic hepatitis
fever janudice abdominal dysfunction coagulopathy, encepholpathy, edema
64
Who to treat with HBV?
High ALT High BBV DNA levels (lower if HBeAg is negative) chronic HBV starting immunosuppressants coinfection with HIV PEP decompensated cirrhosis
65
HBV genetic material
DNA
66
Pathogenesis of Hepatic encephalopathy
gut derived toxins are absorbed and metabolized by the liver cirrhosis - incrased systemic delivery due to inadequate metabolism, portosystemic collaterals, GI tract is primary source of ammonia (anterocytes, colonic bacteria) liver clears all NH4 converting it to urea or glutamine ammonia crosses BBB
67
Mechanism of Wilson's disease
ATP7B genetic defect located in golgi in hepatocytes transfers copper into secretory pway by binding it to ceruloplasmin and facilitates biliar copper excretion defect - Cu over load - free/unprotected Cu attacks cell membranes, enzymes, DNA - oxidative stress and disruption of cell functions
68
Anti-HBsAb
History of HBV infection OR vaccination May not be detectable right after the disappearance of HBsAg (window period)
69
spectrum of alcoholic liver disease
alcoholic steatosis fatty deposition in liver without inflammation (benign reversible) alcoholic hepatitis inflammatory cell infiltrates in context of fatty change alcoholic cirrhosis fibrosis and scarring from chronic inflammation
70
NAFLD spectrum
Fatty Liver, NASH, Cirrhosis 80% have simple fatty liver 20% have NASH 15-30% of NASH will develop cirrhosis over 15 years 7% will develop HCC
71
neuro presentation of wilson's disease
20s, 30s movement (remor) gait (dysarthria, dysphagia) psych - depression, compulsion, phobias
72
HBV inactive carrier state
normal ALT and low HBV DNA
73
primary biliary cirrhosis
autoimmune in women in their 50s fibrosis of bile canaliculi in portal triad anti-mitochondrial antibodies
74
HBeAg
marker of high rate of viral replication
75
Anti-HBc IgG
marker of cleared or chronic HBV infection
76
HDV replication
ssRNA encodes HDAg needs the HBV envelope proteins to enter hepatocytes host rna pol helps HDV replicate in the hepatocyte nucleus co infection w HDV will often lead to more rapid rogression
77
UDPGT
* The bilirubin comes with albumin to the liver to be conjugated * Once it gets to the hepatocytes, inside the hepatocytes, the bilirubin binds to several carrier proteins and gets conjugated via that enzyme UDPGT. This is the crucial enzyme that makes it soluble and able to come out of the biliary tree and excreted into the intestinal tract.
78
Type I HRS
severe, rapidly progressing renal failure 2 wk survival precipitated by EtOH/viral Hep, surgery
79
bilirubin
product of breakdown of hemoglobin A very important function of the liver is to conjugate bilirubin- to make it go into the bile. If the liver can not conjugate it, it can not be excreted. This is the way the body gets rid of break down products of hemoglobin * We produce about 300mg of bilirubin per day. Normally it is excreted. The liver takes it, conjugates it, goes down into the intestinal tract via the biliary tree * If there is an increase in production or the liver can not conjugated it easily, now the bilirubin goes up in blood and that is called hyperbilirubinemia. Also known as jaundice. * Jaundice is that coloration that is due to the increased concentration of the bilirubin. It is seen on the skin and easily on the sclera because the sclera is normally not as colored as skin, you can easily see that coloration
80
Treatment for HRS
albumin (increase reduced EABV) vasoconstrictors (splanchnic vasodilation) TIPS and transpolant
81
bariatric surgery as treatment
not effective in reversing advanced fibrosis in the long term restrictive (intragastric balloon, restrictive devices, gastroplasty) malabsorptive (duodenal sleeve, magnets)
82
aminotransferases
ALT (alanine) AST (aspartate) tested by measuring enzymatic activity important enzymes in AA metabolism, can assess liver cell injury because it's in the hepatocytes how much is in disease depends on how much damage (and previous damage)
83
intrinsic hepatotoxins
predictable injury - direct chemical reaction i.e. Acetomenophen dose dependent necrosis of hepatocytes very high AST/ALT! high mortality
84
detox/excretory liver functions
exogenous (drugs) endogenous (billirubin)
85
treatment of AIH?
prednisone and/or AZA first line goals: normalize LFTs and gamma globulins may be lifelong treatment
86
MDRP-2
protein that allows conjugated bilirubin to be excreted into bile canaliculi into billiary tree and Sb
87
Hepatitis A labs
acute only!! first fecal HAV (infectious!!) then IgM anti-HAV then IgG anti-HAV (immune) •For example in our lab, if you find a patient who possibly have HAV, then IgM is a critical value in the sense that we have to communicate it immediately to the providers that the individual is transmitting HAV. Many times food handlers, restaurants, or somebody handling food in a restaurant and they have IgM anti-HAV. It is transmitted easily by oral-enteral route.
88
AIH-PBC overlap
if have AIH + AMA-positive PBC steroids+azathiprine
89
portal htn in hepatic feins?
CHF budd chiari - OCP clotting clots
90
hepatic encephalopathy
spectrum of potentially reversible impairment in brain function in patients w liver failure, cirrhosis of the liver, or portosystemic shunts
91
liver failure threshold
when \>80% of liver function has been lost as end stage of chronic liver disease or acute form (massive destruction)
92
occular presentation of wilson's
granular Cu deopsition in **Descemet's membrane** - where cornea meets sclera first as a crescent and ultimately a circle 95% also have neuro symptoms
93
ALP
produced by biliary epithelial cells, canalicular hepaocyte membrane also by bone (osteoblasts), placenta, and intestine nl values according to age (vary as growing, pregnancy) * We were talking before about normal ranges. This is one of those enzymes that we have to provide the reference ranges. * Ranges for children: as children are growing, born, they are releasing more ALP. So in children, ALP is higher. * Pregnant women: ALP is produced by the placenta. So again ALP will be normal high in pregnancy [so a high ALP is normal is pregnant women] * These are things to consider when looking at laboratory parameters.
94
HCV replication
ssRNA enveloped detectable 7-21 d after transmission, ALT RAISES 4-12 WKS later!
95
LFTs for hepatocellular injury
Aminotransferases (ALT, AST)
96
Hepatitis B labs
* the earlier indicators of hepatitis will be the surface antigen circulating, the DNA circulating * Later on the antibodies to the core appear * Once antibodies to the surface appear, this individual is already immune meaning this individual will not be transmitting this disease and will not be a carrier. This is very important * All of you here have probably been vaccinated. We should all have antibodies to the surface which means we are immune
97
IgG Anti-HAV
resolved or vaccinated long term resistance can't tell which!
98
hepatic hyperbilirubinemia
defects in uptake (drugs) defects in conjugation hepatocellular damage (hep, drugs, hypoxia) intrahepatic cholesitasis **increased unconjugated and conjugated**
99
esophageal varices
dilated submucosal veins in the lower 1/3 of the esophagus HVPG\>10 - blood flow redirected to collaterals superficial esophageal veins become distended and tortuous 50% of pts w cirrhosis have varices and 5-15% will bleed decompensated cirrhosis - mortality
100
bilirubin breakdown
* Coming again from the spleen and bone marrow and all these reticulo endothelium in which now the bilirubin comes into the liver and gets conjugated and excreted in the bile duct. Once it gets to the intestine there are several steps that break down this conjugated bilirubin. * First by bacteria. These products of this metabolism by bacteria leads to that fecal urobilinogen and other products that are colored. * The reason why our stools are colored is due to this particular mechanism. This is bilirubin that has been metabolized and gives color to the stools * Some of that fecal urobilinogen is reabsorbed from the intestine and could circulate and go to the kidney and we have urinary urobilinogen that is usually colorless. It is not a colored compound.
101
vaccination for HBV?
yes!
102
clinical presentation of PSC
1. **asymptomatic** - normal LFTs and no clinical symptoms, incidental on imaging 2. **biochemical**: elevated LFTs including AP, bili, transaminases 3. **symptomatic**: fatigue, pruritis, weight loss, cholangitis 4. **cirrhosis**
103
corticosteroids for alcoholic hepatitis
prednisolone improves survival in the beginning still high mortality not in infections or w GI bleeds!!
104
presentation of AIH
asymp to debilitating to fulminant 40% with acute hep wax and wane non specific abnormal LFTs, autoabs
105
HDV
depends on HBV! coinfection or superinfection in a patient w chronic HBV superinfections --\> severe hepatitis and decompensation of liver disease
106
lab findings in AIH
increased AST hypergammaglobulnemia increased IgG
107
Hepatic Venous Pressure Gradient
indirect measurement of portal pressure gradient between the portal vein and the abdominal IVC greater than 5 - PHTN greater than 10 - clinically signif PHTN greater than 12 vericeal rupture **WHVP - FHVP**
108
How to diagnose Wilsons?
1. does the patient have low serum ceruloplasmin? 2. Are KF rings present? 3. is the 24 h urinary Cu elevated if yes - def wilsons if no to all 3 - unlinkly wilsons if unusre, liver biopsy or genotyping
109
type 1 hemochromatosis
HFE-related hemochromatosis mutant HFE --\> hepcidin not functional --\> uncontrolled release of Fe into circulation through ferroportin --\> multi rgan Fe deposition vary in genetic alterations in hepcidin reg pway that causes iron homeostasis mech to fail intestinal and macrophage iron unchecked rate of damage determined by gene involved and role in hepcidin biology
110
threshold for alcoholic liver diesaes
no level or duration is directly associated w appearance of clinically significant liver disase risk begins at low leves women more vulnerable
111
steatosis
112
type II AIH autoantibodies
anti-LKM
113
transmissionof HCV
IVDU blood infusions healthcare workers sex perinatal hemodyalisis
114
Clinical findings in PBC
fatigue pruritis Sicca syndrome (xerostomia) Crest portal HTN/varices (even without cirrhosis)
115
Clinical manifestations of acetaminophen overdise
to 24h - nausea, vomiting, malaise, half of injury in 24h 36 h - all aminotransferae elevations - 72-96h - liver abnormalities peak, crazy high AST/ALT if survive - recovery by 7d
116
transmission of HAV
fecal-oral - contaminated food and water person-person sex oysters and shellfish!
117
How do you diagnose PSC?
1. 80% have elevated pANCA 2. MRCP is first test - non invasive - "beaded pattern" with short strictures and dilations
118
How do you determine if chronic HBV infection?
•In a few cases, HBV patients do that recover that way. They don’t develop antibodies to surface. They will remain excreting the antigen. They will have antibody anti-core but they will not have anti-surface. You can detect the virus and e antigen. These are the individuals that may go into chronicity.
119
Progression of Alcoholic Liver Disease
Fatty liver to either steatohep or fibrosis
120
treatment for acetaminophen OD
within 4h give activated charcoal NAC - stimuates hepatic synthesis of glutathione!! after 16h - may be point of no return, but still can help up to 36h
121
diagnosis of HCV
ALT levels fluctuate **HCV Ab** = active or past infection **HCV RNA** level confirms active infection used to monitor response to HCV treatment viral load is unrelated to the degree of fibrosis
122
cholangiocarcinoma and PSC
in 10-15%, 5 month survival worsening LFT and functional status warrent evaluation not a mass lesion - try to brush cells off if see lengthy structure
123
How do you diagnose hemochromatosis?
1. **Fe studies** Elevated TF Saturation \> 45% Ferritin \> 1000 2. **HFE Genetic testing** C282Y homozygote = diagnosis confirmed if not confirmed - consider liver biopsy 3. **Liver biopsy** assess damage and exclude cirrhosis measure hepatic iron concentration via prussian blue stain
124
crigler-najjar type I
inhereted UDPGT disorder unconjugated hyperbilirubinemia \>20 can kill
125
when is jaundice?
\>2-3 mg/dL hyperbilirubinemia (usually about 1 mg circulating) jaundice or icterus of skin, sclera, mucus membranes
126
treatment of HCV
ribavirin w interferon (side effects!!) now we use protease inhibitors - a ton of them in the HCV rep cycle
127
HDV IgM
acute infection with HDV! can persist in chronic infection
128
What enzymes are in cytosol
AST ALT
129
symptoms of HEV
flu like symptoms (most contagious before symptoms) self limited (chronic can occur if immunosuppressed) can cause jaundice high mortality rate in **pregnant women** w fulminant hep!!
130
Anti-HBc Igm
marker of acute infection
131
gold standard for diagnosing cirrhosis?
liver biopsy invasive, bleeding, pain, sampling error
132
coagulation protein synthesis in the liver
most (except VIII) are made in the liver liver disease may also affect Vit K absorption and this factors magnitidue of prothrmobin time (PT) elevation correlates w degree of liver failure
133
nl total bilirubin
.2-.9
134
ferritin
stored iron in liver and heart 1 mlecule can store 4000 Fe atons when excess iron is absorbed, body makes more ferratin
135
wilson's disease
genetic disorder of biliary copper excretion measure Cu in urine and liver biopsy
136
HBV immune tolerant phase
in patientsinfected with HBV at birth/early childhood min inflammation or fibrosis of the liver used to seeing virus so let live in liver - no inflam
137
treatment of HAV
symptomatic treatment fulminant hep may require liver transplant vaccine for PEP or if traveling!
138
HBV replication
1. envelope surrounds partially dsDNA 2. converted to covalently closed circular DNA (cccDNA - dsDNA that's super coiled 3. RT will make RNA that will be translated into proteins that make HBV
139
Treatment for NAFLD/NASH
right now only weight loss through lifestyle modifications! weight loss of 5% can improve liver enzymes no fructose exercise alone can improve liver statosis (without affect on weight or ALT) coffee! decreases fibrosis **all drugs have really bad side effects**- don't work well enough
140
nl direct bilirubin
.1-.3
141
unconjugated bilirubin
indirect - has not been made water soluble ## Footnote •Unconjugated bilirubin: the bilirubin that is produced from the breakdown of hemoglobin that is coming to the liver to be conjugated. So prior to being conjugated, obviously it is called unconjugated, in the lab we measure by a method called the indirect detection of bilirubin
142
Type II HRS
moderate steady decline in renal function relatively preserved lvier function survival 6-12 months
143
symptoms of herediatry hemochromatosis
**bronze diabetes** cirrhosis **bronze skin** **diabetes** joint inflammation (**victory sign**) **heart disease** fatigue **hepatomegaly** (increase ALT, cirrhosis, HCC)
144
DeRitis ratio
AST/ALT ratio \> 2 in alcoholic liver disase * Alcohol induced injury: AST will always be higher than ALT and that helps to distinguish alcohol injury versus others. * AST: has higher concentration inside the hepatocyte. The other thing I wanted to mention is that AST is not only present in the cytoplasm of the hepatocyte but also in the mitochondria. The majority (80%) is in the mitochondria of hepatocyte. Ethanol releases that mitochondrial AST. So it is a very useful test to do is to compare the concentration you receive in your blood test of AST versus ALT. If AST is much higher than the ALT, most likely reason for the injury is alcohol-ethanol. That ratio is called the DeRitis ratio- seen in alcoholic liver disease
145
HBV active phase
elevated aminotransferase levels signs of chronic hep
146
PSC management
no drugs liver transpant is best chance - high recurrance rate soon after
147
primary sclerosing cholangitis
middle-aged men autoimmune destruction of intra and extrahepatic bile ducts P-ANCA, ANA or SMA
148
Where is iron absobed?
duodenum
149
idiosyntratic reactions
necrotic or cholestatic no dose relationship unpredictable hypersensitivity (immuno - augmentin) metabolic (amiodarone) majority!
150
HBsAg
HBV surface ag marker of **acute and chronic** HBV infection persistance in blood for 6 mo means chronic infection
151
hemochromatosis
mutant HFE uncontrolled release of iron from duodenal enterocytes unregulated Fe absorption - in all tissues toxic accumulation of excess iron in multiple irons **defect in hepcidin regulatory pway** autosomal recessive
152
hemochromatosis and malignancy
cirhosis ALWAYS precursor HCC is most common CCA also some HCC-CCA
153
outcomes of chronic HBV
1/3 of patients with chronic HBV acquired in childhood will develop cirrhosis HCC can develop with and without cirrhosis glomerularnephritis
154
Histology of AIH
liver biopsy! mononuclear infiltrate invading throught he limiting plate (**interface hepatitis)** **abundance of plasma cells** **fibrosis**
155
Names of copper chelators?
trientene d-penicillamine
156
HBeAb
seroconversion to LOW replation state not as infevtive
157
mallory bodies
condensation of cytoskeletal intermediary filaments that results when tubulin acetaldehyde adducts form look like red intracellular clumps
158
alcoholic hepatitis
clinical syndrome of janudice and liver function abnormalities in alcohol abusers associated w fast progression to cirrhosis w liver failure pahtology = steatosis, hepatocellular balloooning, neutro[hilic infiltrates, perisinusoidal fibrosis
159
hepcidin
binds to ferroportin to inhibit iron export --\> reduction in intestinal iron absoprption if too much iron --\> high hepcidin --\> blocks export from duodenum --\> don't absorb any more iron!
160
processing/storage liver functions
dietary amino acids carbs lipids vitamins
161
delta bilirubin
Bb tightly bound to albumin (reacts like direct) ## Footnote •Some patients with high direct bilirubinemia because of diseases that direct bilirubinemia builds up in blood. That bilirubin may bind to albumin and that is called delta billirubin. The difference between the delta bilirubin and the unconjugated bilirubin is that this delta bilirubin has a much longer half life because it is bound to albumin. Albumin has a 3wks half life. By being attached to albumin, delta bilirubin gets in circulation for a lot longer.
162
HEV IgG
past infection
163
ascites
pathologic accumulation of fluid in the peritoneal cavity most common comp of cirrhosis distention and pain SOB (push on diaphragm) Early satiety (stomach can't expand) impired quality of life
164
replication of HAV
ssRNA HAV RNA pol copies RNA genome most common cause of acute viral hepatitis vaccinations for HAV have lead to a decrease
165
transient elastography
noninvasive mesure of liver stiffness painless risk free sends sound waves to determine minimal and advanced fibrosis
166
HEV replication
ssRNA no envelope elevation in ALT corresponds with the appearance of HEV abs
167
How to manage variceal bleeding?
**1. vasoconstrictors (reduces splanchnic flow)** BB, ADH, somatostatin **2. venodilators (reduce hepatitic resistance** Nitrates **3. endoscopic treatment** band ligation sclerotherapy **4. TIPS and shunts (decreased resistance)**
168
NASH
non-alcoholic statoheptaitis fat with inflammation, may progress to more advanced disease need a liver biopsy to diagnose
169
LFTs for synthetic function
albumin prothrombin time
170
acetaminophen hepatotoxicity
90% metabolized to conjugates and excreted in urine remainder excreted unchanged in urine or metabolized via CYP to NAPQU (highly reactive and toxic) NAPQI is rapidly conjugated w glutathione and excreted in urine (non toxic) if OD: saturated primary pway, more NAPQU produced - depleted glutathione stores --\> hepatic injury
171
bilirubin in biliary obstruction
high - mostly direct
172
petoxifylline
inhibits synthesis and activity of TNF decreased mortality from hepatorenal syndrome use when steroids contraindicated
173
why is too much iron a bad thing?
target organ damage due to redox activity excesse iron - toxic iron free radicals - oxidative stress - cell damage - fibrosis - cirrhosis
174
What enzymes are in the bile cannaliculi?
GGT ALP
175
transmission of HDV
**exposudre to infected blood or other bodily fluids** IVDU hemodialysis hemophiliacs
176
hemochromatosis
excessive Fe accumulation uncommon - screening with Fe/TIBC - suspicious when \>45%
177
fibrosis/cirrhosis
178
NAPQI
from acetomenophin - byproduct irreversibly binds to hepatic macromolecules - oxidative injury and centrilobular necrosis - ck release from damaged hepatocytes - extension of zone of hepatic injury
179
indirect bilirubin
measuring Bb after adding accelerator substances that solubiliz unconjugated Bb and make it total bilirubin nl: .2-.9 * We have to do some steps in between to solubilize it. * Once we do that, we measure the bilirubin again by the colorimetric assay. Now the bilirubin is going to be higher than the 1st direct step. This one here is the total bilirubin. If we subtract the direct bilirubin from the total that will be our indirect, unconjugated bilirubin. * \>90% of the time, the direct bilirubin represents the conjugated bilirubin. But it is just a way in the lab to help as measure the different fractions of bilirubin
180
conjugated hyperbilirubinemia
defects in bilirubin excretion and bile flow extrahepatic (tubors, choangitis) intrahepatic (viral, alcoholic, drugs, cirrhosis) bc conjugated Bb is water soluble it will be excreted in stools if biliary obstruction --\> absence on Bb in intestine --\> lack of pigment in stools (acholia)
181
two mutations in HFE?
1. **C282Y** - Common homozygotes = type I DM, liver disease etc low penetrance 2. **H63D** (rare) - often normal Fe stores C282Y/C282Y \> C282Y/H638 \> H63D/H63D
182
Markers of HBV infection
incubation: HBsAg acute: HBsAg, anti-HBc after cleared: Anti-HBs
183
hepatocellular carcinoma
aggressive primary liver tumor many associated w HBV or cirrhosis hepatocarcinogenesis linked to chronic liver damage
184
IgM Anti-HAV
acue infection
185
transmission of HEV
fecal-oral route (most are drinking water)
186
LDH
very ubiquitious (muscle, heart, lungs, RBCs) ## Footnote * Can be used to determine certain diseases of the liver; particularly when LDH and ALP go together without affecting much bilirubin is usually seen in space occupying lesions in the liver like tumors for example. So it can also help * Malignant cells that have a very high level of proliferation , they may release very high concentrations of LDH * So even though it is not useful by itself, as part of picture it is of use.
187
ferroportin
Fe is released from enterocytes into plasma through transporter
188
NASH
189
what enzyme is on mitochondria?
AST | (EtOH affects)
190
insulin resistance in NAFLD
almost all patients w NAFLD have insulin resistance lipid overload leads to inappropriate accumulation of lipids in muscle, liver, beta cells lipid metabolites interefere w action of insulin R in the liver **can't suppress glucogenesis** **can't suppress lipolysis** **decreased uptake of glucose** **high glucose, high fatty acids**
191
exposure to children vs adults of HBV
children - 30% will develop chronic adults - 2-5 will develop chronic
192
pre-hepatic hyperbilirubinemia
increased heme production hemolysis sickle cell ineffective erythropoesis (Fe, folate deficiencies) **high unconjugated bilirubin**
193
Transmission of HBV
**percutaneous/mucus membrane exposure** healthcare hemodialysis blood transfusion perinatal IVDU sex tattoos
194
treatment of hepatic encephalopathy
**1. ammonia reduction** non absorbable disaccharides - lactulose - ammonium ion trapping oral abx **2. correct nutritional deficiencies** **3. reduce systemic inflammation** **4. institution of lifelong secondary prophylaxis**
195
MRI-PDFF
protein density fat fraction quantify changes in liver fat - correlation w biopsy and more sensitive to changes
196
HDV IgG
active or past HDV infection
197
post hepatic hyperbilirubinemia
obstruction to bile flow (cholestasis) malignancies **high conjugated bilirubin**
198
autoimmune hepatitis
self perpetuating idiopathic liver inflammation **1. interface hepatitis** **2. hypergammaglobulinemia** **3. autoantibodies** hard to daignose